Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2000 3
2007 1
2010 2
2012 4
2013 4
2014 7
2015 3
2016 5
2017 5
2018 4
2019 7
2020 12
2021 16
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Vitamin D and Its Potential Benefit for the COVID-19 Pandemic.
Charoenngam N, Shirvani A, Holick MF. Charoenngam N, et al. Among authors: shirvani a. Endocr Pract. 2021 May;27(5):484-493. doi: 10.1016/j.eprac.2021.03.006. Epub 2021 Mar 17. Endocr Pract. 2021. PMID: 33744444 Free PMC article. Review.
Vitamin D for skeletal and non-skeletal health: What we should know.
Charoenngam N, Shirvani A, Holick MF. Charoenngam N, et al. Among authors: shirvani a. J Clin Orthop Trauma. 2019 Nov-Dec;10(6):1082-1093. doi: 10.1016/j.jcot.2019.07.004. Epub 2019 Jul 13. J Clin Orthop Trauma. 2019. PMID: 31708633 Free PMC article. Review.
Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial.
Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A, Varzandi T, Mohammadnabi S, Alijani N, Karimi M, Shirvani A, Holick MF. Maghbooli Z, et al. Among authors: shirvani a. Endocr Pract. 2021 Dec;27(12):1242-1251. doi: 10.1016/j.eprac.2021.09.016. Epub 2021 Oct 13. Endocr Pract. 2021. PMID: 34653608 Free PMC article. Clinical Trial.
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, Hadadi A, Montazeri M, Nasiri M, Shirvani A, Holick MF. Maghbooli Z, et al. Among authors: shirvani a. PLoS One. 2020 Sep 25;15(9):e0239799. doi: 10.1371/journal.pone.0239799. eCollection 2020. PLoS One. 2020. PMID: 32976513 Free PMC article.
Reply to S Minisola et al.
Charoenngam N, Kalajian TA, Shirvani A, Yoon GH, Desai S, McCarthy A, Apovian CM, Holick MF. Charoenngam N, et al. Among authors: shirvani a. Am J Clin Nutr. 2021 Sep 1;114(3):1252-1253. doi: 10.1093/ajcn/nqab255. Am J Clin Nutr. 2021. PMID: 34467971 No abstract available.
Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics.
Armin S, Mirkarimi M, Pourmoghaddas Z, Tariverdi M, Jafrasteh A, Marhamati N, Shirvani A, Karimi A, Rafiei Tabatabaei S, Mansour Ghanaei R, Fahimzad S, Shirvani F, Hoseini-Alfatemi SM. Armin S, et al. Among authors: shirvani a. Can J Infect Dis Med Microbiol. 2021 Dec 15;2021:4914371. doi: 10.1155/2021/4914371. eCollection 2021. Can J Infect Dis Med Microbiol. 2021. PMID: 34925657 Free PMC article.
Chitosan: A versatile bio-platform for breast cancer theranostics.
Madamsetty VS, Tavakol S, Moghassemi S, Dadashzadeh A, Schneible JD, Fatemi I, Shirvani A, Zarrabi A, Azedi F, Dehshahri A, Aghaei Afshar A, Aghaabbasi K, Pardakhty A, Mohammadinejad R, Kesharwani P. Madamsetty VS, et al. Among authors: shirvani a. J Control Release. 2022 Jan;341:733-752. doi: 10.1016/j.jconrel.2021.12.012. Epub 2021 Dec 11. J Control Release. 2022. PMID: 34906606 Review.
76 results